Mural Oncology Valuation
| MURA Stock | 3.44 0.20 5.49% |
At this time, the firm appears to be undervalued. Mural Oncology plc secures a last-minute Real Value of USD5.71 per share. The latest price of the firm is USD3.44. Our model forecasts the value of Mural Oncology plc from analyzing the firm fundamentals such as Return On Equity of -1.78, current valuation of (103.86 M), and Shares Owned By Insiders of 1.14 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Mural Oncology's valuation include:
Price Book 0.3566 | Enterprise Value -103.9 M |
Undervalued
Today
Please note that Mural Oncology's price fluctuation is slightly risky at this time. Calculation of the real value of Mural Oncology plc is based on 3 months time horizon. Increasing Mural Oncology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Mural Oncology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Mural Stock. However, Mural Oncology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.44 | Real 5.71 | Target 13.0 | Hype 3.44 |
The real value of Mural Stock, also known as its intrinsic value, is the underlying worth of Mural Oncology plc Company, which is reflected in its stock price. It is based on Mural Oncology's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Mural Oncology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Mural Oncology plc helps investors to forecast how Mural stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Mural Oncology more accurately as focusing exclusively on Mural Oncology's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Mural Oncology's intrinsic value based on its ongoing forecasts of Mural Oncology's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Mural Oncology's closest peers. If more than one evaluation category is relevant for Mural Oncology we suggest using both methods to arrive at a better estimate.
Mural Oncology Cash |
|
Mural Valuation Trend
Comparing Mural Oncology's enterprise value against its market capitalization is a good way to estimate the value of Mural Oncology plc uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Mural Oncology Total Value Analysis
Mural Oncology plc is now projected to have valuation of (103.86 M) with market capitalization of 62.1 M, debt of 15.01 M, and cash on hands of . The negative valuation of Mural Oncology may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Mural Oncology fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(103.86 M) | 62.1 M | 15.01 M |
Mural Oncology Asset Utilization
One of the ways to look at asset utilization of Mural is to check how much profit was generated for every dollar of assets it reports. Mural Oncology plc secures a negative usage of assets of -0.81 %, losing USD0.008105 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Mural Oncology plc shows how discouraging it operates for each dollar spent on its assets.Mural Oncology Ownership Allocation
Mural Oncology plc maintains a total of 17.06 Million outstanding shares. Over half of Mural Oncology's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Mural Oncology Profitability Analysis
Net Loss for the year was (207.45 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Mural Oncology's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Mural Oncology and how it compares across the competition.
About Mural Oncology Valuation
The stock valuation mechanism determines Mural Oncology's current worth on a weekly basis. Our valuation model uses a comparative analysis of Mural Oncology. We calculate exposure to Mural Oncology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Mural Oncology's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -2.6 M | -2.7 M |
Mural Oncology Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 16.7 M |
Mural Oncology Current Valuation Indicators
Valuation refers to the process of determining the present value of Mural Oncology plc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Mural we look at many different elements of the entity such as Mural's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Mural Oncology, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Mural Oncology's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Mural Oncology's worth.Complementary Tools for Mural Stock analysis
When running Mural Oncology's price analysis, check to measure Mural Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mural Oncology is operating at the current time. Most of Mural Oncology's value examination focuses on studying past and present price action to predict the probability of Mural Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mural Oncology's price. Additionally, you may evaluate how the addition of Mural Oncology to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |